Latest Breaking News On - Specific drug use survey - Page 1 : comparemela.com

Nalfurafine capsules 2.5 μg, oral dispersing tablets 2.5 μg) in 1,186 patients with chronic liver disease and intractable pruritus.

Nalfurafine remitchToray industries incJapanese ministry of healthAdministration childJapanese pharmaceutical affairs lawResearch laboratories of toray industries incDrug usePharmaceutical research laboratoriesToray industriesVisual analog scaleSpecific drug use surveyJapanese ministryGood post marketing study practiceConducting post marketing surveillanceJapanese pharmaceutical affairsDrug dependence